Immunicom, Inc.

Calculating rank

USPTO Granted Patents = 5

% Expired Patents = 20.0

Trademarks = 2

Forward Citations = 0

Loading Chart...

10 inventors (with patents filed for the assignee):

Steven Francis Josephs (5 out of 6 patents)

Amir Jafri (4 out of 9 patents)

Mark Raptis (2 out of 29 patents)

4. Robert Segal (2 out of 2 patents)

5. Stephen Michael Prince (2 out of 25 patents)

6. Matthew Ong (1 out of 1 patent)

7. Annette Marleau (1 out of 3 patents)

8. Thomas Emanuel Ichim (1 out of 1 patent)

9. David L Schlotterbeck (1 out of 1 patent)

10. Michael Matho (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 11957825 - Modified TNF as a capture ligand (2024-04-16),

2. 11814430 - Increasing responses to checkpoint inhibitors by extracorporeal apheresis (2023-11-14),

3. 11458236 - Reduced leaching of a ligand (2022-10-04),

4. 11224858 - Reduced leaching of a ligand (2022-01-18),

5. 11123467 - System and method for removal of immune inhibitors from biological fluids (2021-09-21),

Company Overview

Immunicom, Inc. is a biotechnology company focused on developing breakthrough immunotherapies for cancer and other diseases. Their flagship product, the Immunopheresis System, is designed to selectively remove immune-suppressive components from a patient's blood to enhance the body's natural immune response against tumor cells. The company is dedicated to improving outcomes for cancer patients through innovative treatments.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

5 Patents

#875 in San Diego, CA

#12,079 in California

#51,669 in US

San Diego, CA, United States of America

Immunicom, Inc.

Forward Citations = 0

10 inventors:

Steven Francis Josephs (5 out of 6 patents)

Amir Jafri (4 out of 9 patents)

Mark Raptis (2 out of 29 patents)

4. Robert Segal (2 out of 2 patents)

5. Stephen Michael Prince (2 out of 25 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Immunicom, Inc.. Retrieved from https://idiyas.com/company/immunicom

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]